Kortikeral

Triamcinolone acetonide, the active ingredient in Kortikeral, is a topical corticosteroid presented as a combination preparation with salicylic acid for topical use. It is employed to reduce inflammation and promote skin shedding in conditions such as psoriasis, eczema, dermatitis and acne vulgaris, leveraging anti‑inflammatory and keratolytic actions.

GNH USA supplies Kortikeral as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kortikeral, a topical corticosteroid/keratolytic, is used to manage inflammatory and hyperkeratotic skin disorders. - Psoriasis: reduces scaling, redness and plaque thickness, improving skin appearance. - Eczema: alleviates itching, erythema and inflammation for smoother skin. - Dermatitis: controls inflammatory lesions and accelerates healing. - Acne vulgaris: promotes desquamation of clogged pores and diminishes inflammatory lesions.

Topical application of Kortikeral may be associated with local and systemic adverse reactions.

Common Side Effects: - Burning or stinging sensation at the application site. - Skin dryness or flaking. - Pruritus (itching). - Erythema or mild redness. - Folliculitis. - Acneiform eruptions.

Serious or Rare Side Effects: - Skin atrophy or thinning with prolonged use. - Secondary bacterial, fungal or viral infection of treated areas. - Hypopigmentation or depigmentation. - Systemic corticosteroid effects such as adrenal suppression. - Allergic contact dermatitis.

Before prescribing Kortikeral, clinicians should consider the following precautions. - Assess severity: limit use to mild‑moderate disease and avoid extensive body surface coverage. - Duration: restrict continuous treatment to the shortest effective period; discontinue if no improvement within 2‑4 weeks. - Occlusion: avoid occlusive dressings unless directed, as they increase systemic absorption. - Pre‑existing infection: treat any bacterial, fungal or viral skin infection before initiating therapy. - Sensitive skin: use with caution in patients with fragile or atopic skin prone to irritation. - Store at room temperature below 25°C: keep in the original container, protect from moisture and light.

Kortikeral can interact with other topical or systemic agents, affecting absorption or safety.

Major Interactions (Avoid): - Concurrent systemic corticosteroids: may amplify systemic glucocorticoid effects and adrenal suppression. - Occlusive dressings or bandages: significantly increase percutaneous absorption, raising risk of systemic side effects. - Potent antiviral or immunomodulatory creams (e.g., imiquimod): may reduce efficacy of either product.

Moderate Interactions (Monitor Closely): - Topical retinoids: combined use can heighten skin irritation and peeling. - Antifungal agents (e.g., azoles): may increase local irritation or alter barrier function. - Photosensitizing drugs (e.g., tetracyclines): may raise susceptibility to sunburn on treated skin.